Concepedia

Wenjing Su

WS

Statistics

Publications

31

Citations

1.8K

H-Index

21

Active since

2006

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Capital Medical University

Air Force Medical University

First Affiliated Hospital of GuangXi Medical University

Chinese Academy of Sciences

Wenjing Su is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, cell biology, and tumor biology.

Top concepts

MedicineCell BiologyTumor BiologyCancer BiologyCell SignalingRadiation OncologyCancer ResearchCancer Cell BiologyPathologyPharmacology

Publications per year

2006–2024

31

Publications

31

The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression

Wenjing Su, Hyun Ho Han, Yan Wang et al. · Cancer Cell · 2019 · 260 citations · Full text

Coordinating Stemness, Medicine, Immune Suppression +6

RAF inhibitor PLX8394 selectively disrupts BRAF dimers and RAS-independent BRAF-mutant-driven signaling

Zhan Yao, Yijun Gao, Wenjing Su et al. · Nature Medicine · 2018 · 190 citations

Signal Transduction, Braf Dimers, Raf Inhibitor Plx8394 +9

Long noncoding RNA ZEB1-AS1 epigenetically regulates the expressions of ZEB1 and downstream molecules in prostate cancer

Wenjing Su, Miao Xu, Xueqin Chen et al. · Molecular Cancer · 2017 · 166 citations · Full text

ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma

Feng Ji, Peizhi Lu, Guangzhi Zhu et al. · Acta Pharmacologica Sinica · 2020 · 151 citations · Full text

Sorafenib Sensitivity, Hepatology, Medicine +10

The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling

Tomoyo Okada, Surajit Sinha, Ilaria Esposito et al. · Nature Cell Biology · 2014 · 127 citations · Full text

Signaling Pathway, Cell Regulation, Medicine +10

Rows per page

1–5 of 31